Center for Biologics Evaluation And Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative (2018) | Federal Compass

Free Market Report: Trends & Observations
Center for Biologics Evaluation And Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative (2018)


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services » Food and Drug Administration » FDA - Office of Operations » Office of Finance, Budget, Acquisitions, and Planning
NAICS
518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
Competition Set-Aside Type
NONE

Award Type
IDC
Award Date
09/27/2018
Expiration Date
09/25/2023
No. of Awards
4
No. of Offers
5

Obligations by Fiscal Year

prime obligations by fiscal year, trending at -24.88% CAGR

Start Your Free Account Today

Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights

Federal Compass is software designed for today’s federal market.

Explore how the right intel and process can help lead your team to greater success.

Create Free Account

Enjoy instant access to the Federal Compass platform

Contracting Resources